Matthew Maletta
Vermögen: 439 $ am 31.07.2026
Vermögen: 439 $ am 31.07.2026
Matthew Joseph Maletta is currently Secretary at Serica Technologies, Inc. and Vicept Therapeutics, Inc. Starting in 2026, the role of Chief Legal Officer at Viatris, Inc. is held.
Former positions include Director at United Cerebral Palsy from 2012 to 2015, Secretary & Vice President at Allergan, Inc. from 2010 to 2011, Secretary, Chief Legal Officer & Executive Vice President at BioSpecifics Technologies Corp., Chief Legal Officer & Executive Vice President at Endo International Plc from 2015 to 2025, Head-Human Resources & Attorney at AbbVie A, and Secretary, Chief Legal Officer & Executive Vice President at Endo LP from 2024 to 2025.
Education includes undergraduate studies at the University of Minnesota and graduate studies at The University of Minnesota Law School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.03.2026 | 25 ( 0% ) | 439 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| VIATRIS INC. | General Counsel | 09.02.2026 |
Serica Technologies, Inc.
Serica Technologies, Inc. Pharmaceuticals: MajorHealth Technology Distributes silk based biomaterial products for tissue rejuvenation | Unternehmenssekretär | 25.04.2011 |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops dermatologic therapeutic products | Unternehmenssekretär | - |
| Unternehmen | Position | Ende |
|---|---|---|
| ENDO, INC. | General Counsel | 30.07.2025 |
| ENDO INTERNATIONAL PLC | General Counsel | 01.01.2025 |
United Cerebral Palsy
United Cerebral Palsy Services to the Health IndustryHealth Services Provides support services for disables people | Corporate Officer/Principal | 01.01.2015 |
AbbVie A/S (Denmark)
AbbVie A/S (Denmark) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and manufactures medicines | Personalreferent | - |
| BIOSPECIFICS TECHNOLOGIES CORP. | General Counsel | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 11 |
|---|---|
Allergan, Inc.
Allergan, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
BioSpecifics Technologies Corp.
BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology Develops injectable collagenase clostridium histolyticum (CCH) for multiple indications | Health Technology |
Serica Technologies, Inc.
Serica Technologies, Inc. Pharmaceuticals: MajorHealth Technology Distributes silk based biomaterial products for tissue rejuvenation | Health Technology |
Vicept Therapeutics, Inc.
Vicept Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops dermatologic therapeutic products | Health Technology |
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Develops and manufactures immunology, urology, hepatology, generics & sterile injectables therapeutics products | Health Technology |
University of Minnesota
University of Minnesota Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
United Cerebral Palsy
United Cerebral Palsy Services to the Health IndustryHealth Services Provides support services for disables people | Health Services |
Endo, Inc.
Endo, Inc. Pharmaceuticals: MajorHealth Technology Manufactures branded and generic pharmaceuticals & sterile injectables | Health Technology |
The University of Minnesota Law School
The University of Minnesota Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AbbVie A/S (Denmark)
AbbVie A/S (Denmark) Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and manufactures medicines | Health Technology |
Viatris, Inc.
Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen